Author

D. Ando

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 2 Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Organism:human· 1

Frequent Co-Authors

C. Nishiyama· 2 shared K. Nagata· 2 shared M. Ando· 2 shared M. Hachisu· 2 shared N. Ito· 2 shared T. Yashiro· 2 shared A. A. Sharma· 1 shared A. Raad· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

C. Nishiyama

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Kaempferol suppresses the activation of mast cells by modulating the expression of FcϵRI and SHIP1

K. Nagata, S. Araumi, D. Ando, M. Ando, N. Ito, Y. Ikeda, M. Takahashi, S. Noguchi, T. Yashiro, M. Hachisu, C. Nishiyama

This study shows kaempferol suppresses mast cell activation by reducing FcεRI surface expression and increasing SHIP1 levels, independent of transcription and translation.

bioRxiv · Feb 20, 2023Immunology

Butyrate, valerate, and niacin ameliorate anaphylaxis by suppressing IgE-dependent mast cell activation: Roles of GPR109A, PGE2, and epigenetic regulation

K. Nagata, D. Ando, T. Ashikari, K. Ito, R. Miura, I. Fujigaki, M. Ando, N. Ito, H. Kawazoe, Y. Iizuka, M. Inoue, T. Yashiro, M. Hachisu, K. Kasakura, C. Nishiyama

This study shows that butyrate and valerate reduce IgE-mediated mast cell activation by enhancing PGE2 release and GPR109A signaling, while niacin also alleviates anaphylaxis through similar mechanisms.

bioRxiv · Feb 19, 2023Immunology

Infusion of CCR5 Gene-Edited T Cells Allows Immune Reconstitution, HIV Reservoir Decay, and Long-Term Virological Control

J. Zeidan, A. A. Sharma, G. Lee, A. Raad, R. Fromentin, S. Fourati, K. Ghneim, G. P. Sanchez, C. Benne, G. Canderan, F. A. Procopio, R. Balderas, G. Monette, J. P. Lalezari, J. M. Heffernan, , R.-P. Sekaly

This study shows that infusing CCR5 gene-edited T cells improves immune function, reduces HIV reservoirs, and enables long-term viral control without ART.

bioRxiv · Feb 28, 2021 · PreprintImmunology